The DISCOVER study

 

DISCOVER is a global, prospective, observational study of patients with type 2 diabetes who are starting second-line glucose-lowering therapy. The study has enrolled over 15 000 patients in 38 countries across six continents, and will provide a comprehensive and contemporary picture of treatment patterns and outcomes in patients with type 2 diabetes worldwide.

 

Type 2 diabetes and real world evidence

 

The DISCOVER study is designed to generate real world evidence (RWE) about people living with type 2 diabetes across the globe. RWE is key to understanding more about type 2 diabetes and how it is managed in day-to-day clinical practice, and therefore contributes to improved disease management.

 

DISCOVER publications

 

The DISCOVER study will provide unprecedented global insights into the treatment of type 2 diabetes. The DISCOVER Scientific Committee is planning a series of abstracts, posters, presentations and journal articles about the DISCOVER study design and results at global, regional and local levels.

 

DISCOVER activities at the 52nd EASD annual meeting

DISCOVER activities at the 52nd EASD annual meeting

 

Highlights of another successful EASD meeting for DISCOVER.

 

Retention of patients in DISCOVER

Retention of patients in DISCOVER

 

Dr Márcio Antonio Pereira stresses the importance of patient participation in the study in order to improve quality of life.

 

DISCOVER at the 10th DOCLink meeting in Indonesia

DISCOVER at the 10th DOCLink meeting in Indonesia

 

Professor Djoko Wahono, the National Coordinating Investigator of the DISCOVER study in Indonesia, presented the study rationale and key aspects of its design.

 

Thank you from the DISCOVER team

Thank you from the DISCOVER team

 

The DISCOVER team would like to thank all of those involved in DISCOVER for their commitment and hard work in recruiting patients into the study.

 

The DISCOVER study

The DISCOVER study

 

DISCOVER is a global, prospective, observational study of patients with type 2 diabetes who are starting second-line glucose-lowering therapy. The study has enrolled over 15 000 patients in 38 countries across six continents, and will provide a comprehensive and contemporary picture of treatment patterns and outcomes in patients with type 2 diabetes worldwide.

 
 

Type2 diabetes and real world evidence

Type 2 diabetes and real world evidence

The DISCOVER study is designed to generate real world evidence (RWE) about people living with type 2 diabetes across the globe. RWE is key to understanding more about type 2 diabetes and how it is managed in day-to-day clinical practice, and therefore contributes to improved disease management.

 

DISCOVER publications

DISCOVER publications

 

The DISCOVER study will provide unprecedented global insights into the treatment of type 2 diabetes. The DISCOVER Scientific Committee is planning a series of abstracts, posters, presentations and journal articles about the DISCOVER study design and results at global, regional and local levels.